Patents by Inventor Argaw Kidane

Argaw Kidane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896599
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: February 13, 2024
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Publication number: 20230255892
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: November 21, 2022
    Publication date: August 17, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Publication number: 20230210823
    Abstract: Formulations of mazindol having superior stability and methods of administering same are provided. The formulations may be immediate, enhanced, or otherwise delayed release formulations of mazindol.
    Type: Application
    Filed: August 9, 2022
    Publication date: July 6, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P. Bhatt
  • Publication number: 20230081113
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: November 15, 2022
    Publication date: March 16, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Patent number: 11166960
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: November 9, 2021
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Publication number: 20210308142
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: October 27, 2020
    Publication date: October 7, 2021
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Publication number: 20210236510
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 5, 2021
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Publication number: 20210038613
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: October 27, 2020
    Publication date: February 11, 2021
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Publication number: 20200261371
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: February 20, 2020
    Publication date: August 20, 2020
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Publication number: 20190381063
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: January 18, 2019
    Publication date: December 19, 2019
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Publication number: 20190336450
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: December 4, 2018
    Publication date: November 7, 2019
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P. Bhatt
  • Patent number: 10220042
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: March 5, 2019
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Patent number: 10154965
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: December 18, 2018
    Assignee: United Therapeutics Corporation
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Publication number: 20180098996
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility-and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: December 7, 2017
    Publication date: April 12, 2018
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Patent number: 9855278
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: January 2, 2018
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Publication number: 20170056411
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: May 27, 2016
    Publication date: March 2, 2017
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. BHATT, Argaw KIDANE, Kevin EDWARDS
  • Patent number: 9566245
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: February 14, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Publication number: 20160263042
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Patent number: 9393203
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: July 19, 2016
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P Bhatt
  • Patent number: 9370525
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: June 21, 2016
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards